These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 11567967)

  • 1. Uveal tumour resection.
    Char DH; Miller T; Crawford JB
    Br J Ophthalmol; 2001 Oct; 85(10):1213-9. PubMed ID: 11567967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye-wall resection.
    Char DH; Miller T; Crawford JB
    Trans Am Ophthalmol Soc; 2000; 98():153-9; discussion 159-61. PubMed ID: 11190019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internal eye wall resection of uveal tumors: long-term evaluation.
    Moreira CA; Moreira Neto CA
    Arq Bras Oftalmol; 2015; 78(1):47-9. PubMed ID: 25714539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of visual outcome after local resection of choroidal melanoma.
    Damato BE; Paul J; Foulds WS
    Br J Ophthalmol; 1993 Oct; 77(10):616-23. PubMed ID: 8218028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
    Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
    Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma.
    Seregard S; Lundell G; Lax I; af Trampe E; Kock E
    Acta Ophthalmol Scand; 1997 Apr; 75(2):148-54. PubMed ID: 9197561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
    Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
    Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton beam irradiation of uveal melanoma involving the iris, ciliary body and anterior choroid without surgical localisation (light field).
    Oxenreiter MM; Lane AM; Aronow MB; Shih H; Trofimov AV; Kim IK; Gragoudas ES
    Br J Ophthalmol; 2022 Apr; 106(4):518-521. PubMed ID: 33355171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
    Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J
    Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
    Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
    Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoresection of large uveal melanomas: clinical results in a consecutive series of 200 cases.
    Biewald E; Lautner H; Gök M; Horstmann GA; Sauerwein W; Flühs D; Bornfeld N
    Br J Ophthalmol; 2017 Feb; 101(2):204-208. PubMed ID: 27121095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trans-scleral resection of the ciliary body and choroidal melanoma].
    Romanowska-Dixon B; Starzycka M; Pogrzebielski A
    Klin Oczna; 2000; 102(5):323-6. PubMed ID: 11286105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
    Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
    Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up after uveal melanoma charged particle therapy.
    Char DH; Kroll SM; Castro J
    Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreoretinal Surgery in the Prevention and Treatment of Toxic Tumour Syndrome in Uveal Melanoma: A Systematic Review.
    Romano MR; Catania F; Confalonieri F; Zollet P; Allegrini D; Sergenti J; Lanza FB; Ferrara M; Angi M
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Episcleral plaque radiotherapy for uveal melanoma.
    Giblin ME; Shields JA; Augsburger JJ; Brady LW
    Aust N Z J Ophthalmol; 1989 May; 17(2):153-6. PubMed ID: 2667581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for metastatic uveal melanoma after trans-scleral local resection.
    Damato BE; Paul J; Foulds WS
    Br J Ophthalmol; 1996 Feb; 80(2):109-16. PubMed ID: 8814739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.